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Get an infection, take an antibiotic. 
That simple, sensible, and often life-saving 
intervention, repeated myriad times, has triggered 
an ever-escalating war between humans and 
microbes—a war the microbes seem to be 
winning.1 Almost as soon as penicillin was 
introduced in 1942, bacteria started to develop 
resistance. Now, many common bacteria have 
acquired resistance to multiple antibiotics, 
making some infections extraordinarily difficult 
to treat.1,2
Antibiotic resistance is the ability of a 
microorganism to withstand the effects of an 
antibiotic. In Indonesia, antibiotics can be 
purchased even without a doctor’s prescription. 
Now, as bacterial resistance to antibiotic are 
increasing, the potency of an antibiotic to eradicate 
pathogenic bacteria seems to be decreasing, not 
very long after a new antibiotic is available in the 
market. Generally, the development of resistant 
bacteria to antibiotics happen spontaneously or 
because of a pressure of inappropriate antibiotic 
use in clinical practice. In Indonesia, the absence 
of antibiotic regulation to be used in human as 
well as animal health is also believed to have 
contributed to the rapidly increasing incidence 
of multidrug resistant bacteria. The antibiotic 
resistant bacteria has become a serious problem 
especially for patients hospitalized in intensive 
care units. More than 40% of the budget for drugs 
is allocated for antibiotics, and once the causative 
bacteria develops resistance to antibiotics, the 
case fatality rate of the infections increases.
Data on antibiotic resistance pattern from 
several hospital isolates in Indonesia showed 
an increase in resistance rates, not only in 
Gram negative bacteria such as Pseudomonas 
aeruginosa, Enterobacteriaceae, Klebsiella 
peumoniae and Acinetobacter baumanii, 
but also in Gram positive bacteria such as 
Staphylococcus aureus. Isolation of methicillin 
resistant Staphylococcus aureus (MRSA) 
which is more resistant to antibiotics from the 
beta-lactam group are also reported in several 
hospitals. Although there is no report on the 
isolation of MRSA from the community, the 
existence of this super bug is an indicator that 
nonrational use of antibiotic in Indonesia is 
highly practiced. Antibiotic resistant bacteria is 
also the major problem for patient care in the 
intensive care unit. The problem is dramatically 
increased whenever the causative bacteria is a 
multidrug resistant bacteria, meaning that the 
bacteria isolated from patients are resistant to 
more than one category of antibiotics, such as 
resistant to beta-lactam groups of antibiotics, at 
the same time also resistant to fluoroquinolones 
or aminoglycosides. Multidrug resistant bacteria 
such as Pseudomonas aeruginosa and Klebsiella 
pneumonia, were also isolated from ICU of 
Fatmawati Hospital, Jakarta. Most of them were 
resistant both to third generation Cephalosporin 
and Fluoroquinolones.3 These resistant bacteria 
are categorized in a group called extended 
spectrum beta-Lactamase producing bacteria 
(ESBL), which show a multidrug resistant 
bacteria mainly to beta lactam antibiotics. The 
increase of ESBLs in Indonesia has been proven 
by clinical microbiology laboratories, among 
others as reported by Karuniawati A, et al.4 
Molecular epidemiology studies of antibiotic 
resistant pathogens in Indonesia are very rare, 
and this study conducted on clinical isolates 
from intensive care unit of Cipto Mangunkusumo 
Hospital in 2011 showed that the prevalence of 
carbapenem resistant Gram negative pathogens 
are increased in Enterobacteriaceae 27.6%, 
Pseudomonas aeruginosa 21.9% and in 
Acinetobacter baumanii 50.5%. Using such 
molecular epidemiology technique applied to 
antibiotic resistant strain isolated in hospital, a 
certain common genes among isolates can be 
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determined. The data obtained from molecular 
epidemiology study will be very useful for 
the development of an antibiotic guideline for 
physician working in that specific hospital. 
This evidence based hospital guidelines to treat 
infections in hospital will improve the quality of 
hospital prescription for antibiotics delivered by 
the clinicians.
Saharman YR and Lestari DC,5 present an 
interesting data on a simple modified Hodge test 
method to detect the existence of carbapenemase.5 
The result shows the high prevalence of ESBLs 
in hospital isolates in Jakarta. This result shows 
similar pattern with results obtained from the 
similar surveillance conducted in other parts 
of Indonesia. A total of 300 ESBL-producing 
isolates have been collected in 2010 from three 
other teaching hospitals, i.e. in Semarang, Malang 
and Surabaya, with three most prevalent ESBL 
producers being Escherichia coli, Klebsiella 
pneumoniae, and Enterobacter spp.6 Routine 
examination and surveillance for hospital’s bug 
should be conducted more often. This shows 
the important role of a clinical microbiology 
experts working together with other clinicians in 
hospital. To look for those superbugs mentioned 
above and to limit the spreading of hospital 
acquired infections, a robust and efficient clinical 
microbiology laboratory should be established 
in hospital.
Given the alarming problems of antibiotic 
resistant bacteria in hospital setting, we should 
look into the quality of antimicrobial drug 
prescription in hospital. J.W.M. van der Meer6 
mentioned in his very interesting publication that 
even in The Netherlands where both antibiotic 
consumption and antibiotic resistant bacteria are 
low, the antimicrobial prescription is not optimal. 
In his survey, 15% of antibiotic therapy in surgical 
and internal medicine wards are not adequate. The 
major problem of an inappropriate prescribing is 
due to insufficient education about infectious 
diseases and antimicrobial therapy.7 Adjustment 
of the initial antimicrobial therapy based on the 
clinical microbiology result and clinical course 
is one of the most relevant steps in antimicrobial 
prescribing, since it is clearly diminishes the 
selection pressure to microorganisms in hospital. 
Many physicians who prescribed antibiotic, 
does not even understand if their appropriate or 
inappropriate prescription can have an impact on 
bacterial resistance development. A reasonable 
and evidence based antibiotic guidance is one 
tool toward good antibiotic prescription. A clear 
antibiotic guidance in hospitals should be able 
to identify specific antibiotic use for oral versus 
parenteral therapy, combination versus single 
drug therapy and guidelines in changing between 
one antibiotic to other antibiotic whenever 
necessary. A continuous effort in hospital 
surveillance, infection control and clinical 
audits must be conducted as a routine hospital 
management to fight against the development of 
antibiotic resistant pathogens.
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